670nm - A stop sign for retinal degenerations?

K. Valter, R. Albarracin, R. Natoli, M. Rutar, J. Provis

    Research output: Chapter in Book/Report/Conference proceedingConference contributionpeer-review

    Abstract

    This article presents a review of the work conducted in our laboratories using the 670nm light to test its efficacy in preventing or slowing the progression of retinal degeneration in the rodent retinal light-damage model. Using this model as an archetype of dry age-related macular degeneration we propose that 670nm light could be a viable option in the treatment of human AMD. We have found that irradiation of the eye with the 670nm light, using LED light arrays showed beneficial effects in photoreceptor survival1, 2, vascular development3 and moderating glial activation4 in a variety of rodent models. Based on these findings, we believe that photobiomodulation with 670nm red light has a great potential in retinal therapeutics, providing a non-invasive, and cost-effective treatment in retinal injury and degenerative conditions.

    Original languageEnglish
    Title of host publicationProceedings of the WALT Biennial Congress and NAALT Annual Conference
    EditorsE.-Liisa Laakso
    PublisherMEDIMOND s.r.l.
    Pages33-38
    Number of pages6
    ISBN (Electronic)9788875877231
    Publication statusPublished - 2014
    Event2014 WALT Biennial Congress and NAALT Annual Conference - Arlington, United States
    Duration: 9 Sept 201412 Sept 2014

    Publication series

    NameProceedings of the WALT Biennial Congress and NAALT Annual Conference

    Conference

    Conference2014 WALT Biennial Congress and NAALT Annual Conference
    Country/TerritoryUnited States
    CityArlington
    Period9/09/1412/09/14

    Fingerprint

    Dive into the research topics of '670nm - A stop sign for retinal degenerations?'. Together they form a unique fingerprint.

    Cite this